Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WHO SOLIDARITY trial for hospitalized adults with COVID-19
ISRCTN83971151Phase 3Completed
- Sponsor
- World Health Organization
- Start
- Mar 2020
- Modality
- Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of remdesivir, chloroquine, hydroxychloroquine, lopinavir, ritonavir and 1 more in coronavirus disease 2019 (COVID-19) (5 arms), sponsored by World Health Organization. Primary endpoint: All-cause mortality. Started Mar 2020; status: completed.
02
Drugs
remdesivirchloroquinehydroxychloroquinelopinavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN83971151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN83971151.